Overview
- The Cleveland Clinic agreed to a decades-long ban on offering puberty blockers, cross-sex hormones and other sex-rejecting procedures to patients under 18 and to pay $308,000 to resolve alleged false billing.
- The settlement requires the clinic to dedicate $2 million to provide and publicize multidisciplinary detransition services, including endocrine care, surgical revision, fertility restoration and mental-health support regardless of ability to pay.
- The agreement, announced Thursday, credits the clinic for cooperating with investigators and does not include any admission of liability by Cleveland Clinic.
- The Cleveland Clinic deal follows a larger May settlement with Texas Children’s Hospital that included a $10 million payment and similar care restrictions, and the Justice Department says related Civil Division investigations remain active.
- Reactions split along political and medical lines with some officials praising enforcement and critics and trans-health groups warning the pact will reduce access to gender-affirming care for minors and further politicize medical practice.